We use cookies to personalise content and ads, to provide social media features and to analyse our traffic. We also share information about your use of our site with our social media, advertising and analytics partners who may combine it with other information that you’ve provided to them or that they’ve collected from other web pages that is not governed by us.
Course catalog
Four Key Plenaries from the 2024 CHEP+ Conference on Preventing Vascular Cognitive Impairment
Four Key Plenaries from the 2024 CHEP+ Conference on Preventing Vascular Cognitive Impairment
Preventing stroke in people with heart disease. Preventing heart disease in people with stroke.
Preventing stroke in people with heart disease. Preventing heart disease in people with stroke.
Why Patients Don’t Adhere: Addressing Social Determinants and Treatment Burden in Complex Care
Why Patients Don’t Adhere: Addressing Social Determinants and Treatment Burden in Complex Care
An approach to managing the increased risk of vascular cognitive impairment in people with atrial fibrillation
An approach to managing the increased risk of vascular cognitive impairment in people with atrial fibrillation
Approach to heart failure and vascular cognitive impairment
Approach to heart failure and vascular cognitive impairment
An approach to managing the increased risk of depression in people with heart disease.
An approach to managing the increased risk of depression in people with heart disease.
Intensified blood pressure lowering in adults at high risk of CVD to prevent vascular cognitive impairment.
Intensified blood pressure lowering in adults at high risk of CVD to prevent vascular cognitive impairment.
Vaccination against influenza, pneumococcal diseases, and shingles prevents more than just the infectious disease
Vaccination against influenza, pneumococcal diseases, and shingles prevents more than just the infectious disease
Dr. Jodi Edwards on identifying the the risk for VCI 15 minutes
Dr. Jodi Edwards on identifying the the risk for VCI 15 minutes
Gefry, a 63-year-old male with type 2 diabetes you have called in to talk about routine screening for diabetic nephropathy.
Gefry, a 63-year-old male with type 2 diabetes you have called in to talk about routine screening for diabetic nephropathy.
Learn about the role of SGLT2i in the management of patients with heart failure.
Learn about the role of SGLT2i in the management of patients with heart failure.
Learn about the role of SGLT2i as kidney protection including tips about other kidney protective agents for patients with advanced nephropathy from type 2 diabetes
Learn about the role of SGLT2i as kidney protection including tips about other kidney protective agents for patients with advanced nephropathy from type 2 diabetes